An expert review panel on medical isotope production delivered a report to Canada’s minister of natural resources, stating that the path to security of the isotope supply lay in diversied plan, including buidling a new reactor as a source of production.
The U.S. Department of Energy (DOE) has entered a cooperative agreement with Michigan State University (MSU) to provide financial assistance to design and establish the university's Facility for Rare Isotope Beams.
Atomic Energy of Canada Limited’s (AECL) NRU reactor was restarted on Dec. 11, following the completion of its scheduled, but extended, maintenance outage that lasted one week. However, the medical shortage continues to baffle the nuclear medicine community.
Scientists in Canada have discovered that intense beams of light could generate isotopes for nuclear medicine and eliminate the security risks associated with making the medicines with weapons-grade uranium at the aging nuclear reactor in Chalk River, Ont.
Nuclear Research and Consultancy Group (NRG), which operates the recently shuttered nuclear reactor in Petten, in northwestern Netherlands, announced Wednesday it would not restart the reactor before the end of October.
|
The long-standing shutdown of the Chalk River nuclear reactor has jeopardized the supply of radioactive iodine to treat thyroid cancer to such an extent that Health Canada has fast-tracked the approval of an Iodine-131 supply from the South African Safari reactor, according to a report in the Toronto Sun.
The University of Missouri has initiated a project that could potentially make the university the producer of half the supply of molybdenum-99 in the United States within four years.
The U.S. Department of Energy has selected Michigan State University in East Lansing, Mich., to design and establish the Facility for Rare Isotope Beams, a research facility to advance understanding of nuclear isotopes and the evolution of the cosmos.
Following the shutdowns of the High Flux Reactor, in Petten,
Netherlands, and the IRE production site, in Fleurus, Belgium, both of
which provide the radioisotope molybdenum, the Association of
Imaging Producers and Equipment Suppliers (AIPES) has assembled
stakeholders, from reactor operators to physicians, to ensure isotope
delivery.
Advanced Medical Isotope Corporation has entered into a
five-year agreement with Central Radiopharmaceutical Services for
the joint production and marketing of Indium-111, an isotope used in
specialized diagnostic imaging applications.
|